The impact of C-reactive protein on risk of stroke, stroke subtypes, and ischemic heart disease in middle-aged Japanese: The Japan public health center-based study

Journal of Atherosclerosis and Thrombosis

Volumn 19, Issue 8, 2012, Pages 756-766

  Iso, Hiroyasu ^a   Noda, Hiroyuki ^a,b   Ikeda, Ai ^a,b   Yamagishi, Kazumasa ^c   Inoue, Manami ^d   Iwasaki, Motoki ^d   Tsugane, Shoichiro ^d  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d NATIONAL CANCER CENTER   (Japan)

Author keywords

Follow up studies; High sensitivity C reactive protein; Ischemic heart disease; Risk factors; Stroke

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; BODY MASS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INFARCTION; ISCHEMIC HEART DISEASE; JAPANESE; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PREDICTIVE VALUE; PUBLIC HEALTH SERVICE; STROKE; SUDDEN DEATH;

EID: 84865774326     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.11999     Document Type: Article

References (45)

1. Danesh J, Collins R, Appleby P, Peto R: Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA, 1998; 279: 1477-1482
2. Arima H, Kubo M, Yonemoto K, Doi Y, Ninomiya T, Tanizaki Y, Hata J, Matsumura K, Iida M, Kiyohara Y: High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study. Arterioscler Thromb Vasc Biol, 2008; 28: 1385-1391
3. Bos MJ, Schipper CM, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM: High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation, 2006; 114: 1591-1598
4. Wakugawa Y, Kiyohara Y, Tanizaki Y, Kubo M, Ninomiya T, Hata J, Doi Y, Okubo K, Oishi Y, Shikata K, Yonemoto K, Maebuchi D, Ibayashi S, Iida M: C-reactive protein and risk of first-ever ischemic and hemorrhagic stroke in a general Japanese population: the Hisayama Study. Stroke, 2006; 37: 27-32
5. Iso H, Cui R, Date C, Kikuchi S, Tamakoshi A; JACC Study group: C-reactive protein levels and risk of mortality from cardiovascular disease in Japanese: the JACC Study. Atherosclerosis, 2009; 207: 291-297
6. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med, 1997; 336: 973-979
7. Everett BM, Kurth T, Buring JE, Ridker PM: The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women. J Am Coll Cardiol, 2006; 48: 2235-2242
8. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med, 2002; 347: 1557-1565
9. Cao JJ, Thach C, Manolio TA, Psaty BM, Kuller LH, Chaves PH, Polak JF, Sutton-Tyrrell K, Herrington DM, Price TR, Cushman M: C-reactive protein, carotid intimamedia thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. Circulation, 2003; 108: 166-170
10. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, D'Agostino RB, Franzblau C, Wilson PW: Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke, 2001; 32: 2575-2579
11. Ballantyne CM, Hoogeveen RC, Bang H, Coresh J, Folsom AR, Chambless LE, Myerson M, Wu KK, Sharrett AR, Boerwinkle E: Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med, 2005; 165: 2479-2484
12. Curb JD, Abbott RD, Rodriguez BL, Sakkinen P, Popper JS, Yano K, Tracy RP: C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation 2003; 107: 2016-2020
13. Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG: Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med, 2008; 359: 1897-1908
14. Makita S, Nakamura M, Satoh K, Tanaka F, Onoda T, Kawamura K, Ohsawa M, Tanno K, Itai K, Sakata K, Okayama A, Terayama Y, Yoshida Y, Ogawa A: Serum C-reactive protein levels can be used to predict future ischemic stroke and mortality in Japanese men from the general population. Atherosclerosis, 2009; 204: 234-238
15. Chei CL, Yamagishi K, Kitamura A, Kiyama M, Imano H, Ohira T, Cui R, Tanigawa T, Sankai T, Ishikawa Y, Sato S, Iso H: C-reactive protein levels and risk of stroke and its subtype in Japanese: The Circulatory Risk in Communities Study (CIRCS). Atherosclerosis, 2011; 217: 187-193
16. Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P: N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA, 2005; 293: 1609-1616
17. Tanizaki Y, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Shinohara N, Arima H, Tanaka K, Ibayashi S, Fujishima M: Incidence and risk factors for subtypes of cerebral infarction in a general population: The Hisayama study. Stroke, 2000; 31: 2616-2622
18. Ohira T, Shahar E, Chambless LE, Rosamond WD, Mosley TH Jr, Folsom AR: Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study. Stroke, 2006; 37: 2493-2498
19. van Dijk EJ, Prins ND, Vermeer SE, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM: C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation, 2005; 112: 900-905
20. Tsugane S, Sobue T: Baseline survey of JPHC study--design and participation rate. Japan Public Health Centerbased Prospective Study on Cancer and Cardiovascular Diseases. J Epidemiol, 2001; 11: S24-29
21. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A: Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and casefatality rates in 38 populations from 21 countries in four continents. Circulation, 1994; 90: 583-612
22. Walker AE, Robins M, Weinfeld FD: The National Sur vey of Stroke. Clinical findings. Stroke 1981; 12: 113-144
23. Iso H, Rexrode K, Hennekens CH, Manson JE. Application of computer tomography-oriented criteria for stroke subtype classification in a prospective study. Ann Epidemiol, 2000; 10: 81-87
24. Clayton D, Hills M: 16.5 Incidence density sampling. In: Clayton D, Hill M. Statitical models in epidemiology. New York: Oxford University Press, 1993: pp 161-162
25. Saito I, Sato S, Nakamura M, Kokubo Y, Mannami T, Adachi H, Konishi M, Okada K, Iso H, Kario K, Ohsuzu F, Momiyama Y, Tsushima M: A low level of C-reactive protein in Japanese adults and its association with cardiovascular risk factors: the Japan NCVC-Collaborative Inflammation Cohort (JNIC) study. Atherosclerosis, 2007; 194: 238-244
26. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 2003; 107: 499-511
27. Nakamura M, Sato S, Shimamoto T: Improvement in Japanese clinical laboratory measurements of total cholesterol and HDL-cholesterol by the US Cholesterol Reference Method Laboratory Network. J Atheroscler Thromb, 2003; 10: 145-153
28. Rothman KJ, Greenland S: Measures of effect and association. In: Modern Epidemiology. Philadelphia, Pa: Lippincott Williams & Wilkins; 1998: 47-64
29. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-172
30. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med, 1999; 340: 448-454
31. Paul A, Ko KW, Li L, Yechoor V, McCrory MA, Szalai AJ, Chan L: C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation, 2004; 109: 647-655
32. Corrado E, Rizzo M, Coppola G, Fattouch K, Novo G, Marturana I, Ferrara F, Novo S: An update on the role of markers of inflammation in atherosclerosis. J Atheroscler Thromb, 2010; 17: 1-11
33. Yamagishi T, Kato M, Koiwa Y, Omata K, Hasegawa H, Kanai H: Evaluation of plaque stabilization by fluvastatin with carotid intima-medial elasticity measured by a transcutaneous ultrasonic-based tissue characterization system. J Atheroscler Thromb, 2009; 16: 662-673
34. Sakurai S, Kitamura A, Cui R, Yamagishi K, Tanigawa T, Iso H: Relationships of soluble E-selectin and high-sensitivity C-reactive protein with carotid atherosclerosis in Japanese men. J Atheroscler Thromb, 2009; 16: 339-345
35. Noda H, Iso H, Yamashita S, Ueno H, Yokode M, Yamada N, Ouchi Y; Defining Vascular Disease (DVD) Research Group: Risk stratification based on metabolic syndrome as well as non-metabolic risk factors in the assessment of carotid atherosclerosis. J Atheroscler Thromb, 2011; 18: 504-512
36. Konishi M: Epidemiological studies on cerebrovascular diseases with the special references to the pathological findings on stroke in Akita district. Nihon Koshu Eisei Zasshi, 1974; 21: 485-500 (in Japanese)
37. Konishi M, Ozawa H, Iida M, Shimamoto T, Ueshima H, Tanigaki M, Komachi Y: Epidemiological studies of cerebro-and cardiovascular diseases in Japan: With the special references to the pathological findings on myocardial infarction in Akita district. Nihon Koshu Eisei Zasshi, 1979: 26; 1-12 (in Japanese)
38. Konishi M: Origin and transition of cardiovascular disease among Japanese: Insight from patho-epidemiological study in Akita: the third volume. Nihon Iji Shinpou, 2009; 4443: 53-59 (in Japanese)
39. Sato S, Iso H, Noda H, Kitamura A, Imano H, Kiyama M, Ohira T, Okada T, Yao M, Tanigawa T, Yamagishi K, Nakamura M, Naito Y, Shimamoto T: Plasma fibrinogen concentrations and risk of stroke and its subtypes among Japanese men and women. Stroke, 2006; 37: 2488-2492
40. Noda H, Iso H, Saito I, Konishi M, Inoue M, Tsugane S: The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study. Hypertens Res, 2009; 32: 289-298
41. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005; 352: 1685-95
42. Lammie GA. Pathology of small vessel stroke. Brit Med Bull, 2000; 56: 296-306
43. Nakamura M, Sato S, Shimamoto T: Establishment of external quality control program for hs-CRP and threeyear follow-up of the performance for precision and accuracy. J Atheroscler Thromb, 2007; 14: 287-293
44. Iwasaki M, Yamamoto S, Otani T, Inoue M, Hanaoka T, Sobue T, Tsugane S; Japan Public Health Center-based Prospective Study Group: Generalizability of relative risk estimates from a well-defined population to a general population. Eur J Epidemiol, 2006; 21: 253-262
45. Nilsson TK, Boman K, Jansson JH, Thøgersen AM, Berggren M, Broberg A, Granlund A: Comparison of soluble thrombomodulin, von Willebrand factor, tPA/PAI-1 complex, and high-sensitivity CRP concentrations in serum, EDTA plasma, citrated plasma, and acidified citrated plasma (Stabilyte) stored at-70 degrees C for 8-11 years. Thromb Res, 2005; 116: 249-254